David Wilkes
Director/Board Member at BAXTER INTERNATIONAL INC.
Net worth: 695 551 $ as of 2024-03-30
Profile
David S.
Wilkes is the founder of ImmuneWorks, Inc. which was founded in 2006, where he holds the title of Chief Scientific Officer.
Currently, he is an Independent Director at Baxter International, Inc. and a Trustee at Villanova University.
In the past, he served as the National Director-Development Program at The Robert Wood Johnson Foundation, and as an Independent Director at Syneos Health, Inc. from 2021 to 2023.
He also served as the Dean-Emeritus at The University of Virginia School of Medicine from 2015 to 2021, and as the Dean at The Indiana University School of Medicine from 2009 to 2015.
Dr. Wilkes holds a doctorate degree from Temple University (Pennsylvania) and an undergraduate degree from Villanova University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2024-05-06 | 16,274 ( 0.00% ) | 695 551 $ | 2024-03-30 |
David Wilkes active positions
| Companies | Position | Start |
|---|---|---|
| BAXTER INTERNATIONAL INC. | Director/Board Member | 2021-02-14 |
ImmuneWorks, Inc.
 ImmuneWorks, Inc. BiotechnologyHealth Technology ImmuneWorks, Inc. develops autoimmune lung diseases treatment. It offers therapeutic asset for idiopathic pulmonary fibrosis (IPF) and additional fibrotic lung diseases. The company was founded by David S. Wilkes, Ronald L. Meeusen, and Michael J. Klemsz in January 2006 and is headquartered Indianapolis, IN. | Founder | 2005-12-31 |
| Villanova University | Director/Board Member | - |
Former positions of David Wilkes
| Companies | Position | End |
|---|---|---|
| SYNEOS HEALTH, INC. | Director/Board Member | 2023-09-27 |
| The University of Virginia School of Medicine | Corporate Officer/Principal | 2020-12-31 |
| The Indiana University School of Medicine | Corporate Officer/Principal | 2014-12-31 |
The Robert Wood Johnson Foundation
 The Robert Wood Johnson Foundation Investment Trusts/Mutual FundsMiscellaneous The Robert Wood Johnson Foundation (RWJF) is an independent philanthropic organization headquartered in Princeton, New Jersey. The firm was founded in 1972 and is dedicated solely to health. RWJF funds a wide array of programs which are working to help build a national Culture of Health. | Corporate Officer/Principal | - |
Training of David Wilkes
| Temple University (Pennsylvania) | Doctorate Degree |
| Villanova University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| BAXTER INTERNATIONAL INC. | Health Technology |
| Private companies | 3 |
|---|---|
The Robert Wood Johnson Foundation
The Robert Wood Johnson Foundation Investment Trusts/Mutual FundsMiscellaneous The Robert Wood Johnson Foundation (RWJF) is an independent philanthropic organization headquartered in Princeton, New Jersey. The firm was founded in 1972 and is dedicated solely to health. RWJF funds a wide array of programs which are working to help build a national Culture of Health. | Miscellaneous |
ImmuneWorks, Inc.
ImmuneWorks, Inc. BiotechnologyHealth Technology ImmuneWorks, Inc. develops autoimmune lung diseases treatment. It offers therapeutic asset for idiopathic pulmonary fibrosis (IPF) and additional fibrotic lung diseases. The company was founded by David S. Wilkes, Ronald L. Meeusen, and Michael J. Klemsz in January 2006 and is headquartered Indianapolis, IN. | Health Technology |
Syneos Health, Inc.
 Syneos Health, Inc. BiotechnologyHealth Technology Syneos Health, Inc. engages in the provision of biopharmaceutical solutions. It operates through the Clinical Solutions and Commercial Solutions segments. The Clinical Solutions segment offers global services for the development of diagnostics, drugs, biologics, devices, and digital therapeutics that span Phase I to IV of clinical development. It also offers individual services including regulatory consulting, project management, protocol development, investigational site recruitment, clinical monitoring, technology-enabled patient recruitment and engagement, clinical home health services, clinical trial diversity, biometrics, and regulatory affairs. The Commercial Solutions segment provides commercialization services, including deployment solutions, communications solutions, and consultancy services. The company was founded in 1998 and is headquartered in Morrisville, NC. | Health Technology |
- Stock Market
- Insiders
- David Wilkes
